A rabbit model for human cytomegalovirus-induced chorioretinal disease

E C Dunkel1, D de Freitas, D I Scheer

  • 1Schepens Eye Research Institute, Department of Ophthalmology, Boston, MA 02114.

Insights

Researchers developed a rabbit model for human cytomegalovirus (HCMV) chorioretinitis. This model mimics progressive ocular disease, aiding in studying HCMV pathogenesis and testing antiviral therapies.

Area of Science:

  • Ophthalmology
  • Virology
  • Immunology

Background:

  • Human cytomegalovirus (HCMV) causes significant ocular disease, particularly in immunocompromised individuals.
  • Current understanding of HCMV ocular pathogenesis and effective treatment strategies is limited.
  • There is a need for robust animal models to study HCMV chorioretinitis.

Purpose of the Study:

  • To establish a novel rabbit model of progressive human cytomegalovirus (HCMV) chorioretinal disease.
  • To investigate the pathogenesis of HCMV ocular infection in an animal model.
  • To provide a platform for evaluating new antiviral therapies and immune modulation strategies for HCMV eye infections.

Main Methods:

  • Injection of 10(5) plaque-forming units (pfu) of the AD169 HCMV strain into the rabbit vitreous.
  • Monitoring disease progression through HCMV recovery, clinical observation, antigen localization via immunofluorescence, and histopathology.
  • Analysis of chorioretinal, vitreous, and pulmonary tissues.

Main Results:

  • Progressive chorioretinal disease characterized by vitritis and retinal inflammation was successfully established.
  • Histopathology revealed immune cellular infiltrates, retinal destruction, and choroidal edema.
  • HCMV was consistently recovered from ocular tissues, and viral antigens were detected in retinal layers.

Conclusions:

  • The developed rabbit model accurately replicates key features of human HCMV chorioretinitis.
  • This model serves as a valuable tool for elucidating HCMV ocular disease mechanisms.
  • It facilitates the preclinical evaluation of novel antiviral agents and immunomodulatory approaches for HCMV-induced eye infections.

Related Concept Videos